| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |